Sign in
4/A

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465826-12-000010

Options or other derivatives

  • Director acquired 125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Underlying Owned after D/I
2012-03-15 Grant or award : show line 1 in the form Series E Preferred Stock +125 $1,000.00 $125,000 $0.02 5,082,301 1,750 I
Loading xslF345X03/primary_doc.xml…